Contractor
RADHA PHARMACEUTICALS INC
- UEI
- C1S5SQ88KY67
- Parent UEI
- C1S5SQ88KY67
- Resolved by
- uei
- Confidence
- 1.000
Active from Aug 24, 2022 to Sep 14, 2026.
Sign in to watchRecent awards
| Award | Agency | Place | First action | Current value |
|---|---|---|---|---|
| 36E79725D0043 NEW AWARD FOR RANOLAZINE SUSTAINED ACTION TABLETS WITH RADHA PHARMACEUTICALS INC. BASE YEAR ORDERING PERIOD IS NOVEMBER 20, 2025 TO NOVEMBER 19, 2026 WITH FOUR ONE-YEAR OPTIONS. | Department of Veterans Affairs | — | Jun 26, 2025 | — |
| 36E79725D0044 NEW AWARD FOR BUSPIRONE HCL TABLETS WITH RADHA. ORDERING PERIOD IS OCT 3, 2025 TO OCT 2, 2026 WITH FOUR ONE-YEAR OPTIONS | Department of Veterans Affairs | — | Aug 4, 2025 | — |
| 36E79726D0013 NEW AWARD FOR HYDRALAZINE HCL TABLETS WITH RADHA PHARMACEUTICALS WITH FOUR ONE-YEAR OPTIONS | Department of Veterans Affairs | — | Jan 28, 2026 | — |
| 36E79726D0029 NEW AWARD FOR NAPROXEN TABLETS WITH RADHA PHARMACEUTICALS, INC. PERIOD OF PERFORMANCE IS 8/1/2026-7/31/2027. | Department of Veterans Affairs | — | Apr 16, 2026 | — |
| 36E79723D0025 AWARD TO RADHA PHARMACEUTICALS INC FOR ATORVASTATIN CALCIUM TABLETS FOR THE BASE YEAR WITH FOUR ONE-YEAR OPTIONS. | Department of Veterans Affairs | — | Jul 18, 2023 | — |
| 36E79725D0026 2 LINE ITEMS: CARBIDOPA 25MG/LEVODOPA 100MG TAB,SA CARBIDOPA 50MG/LEVODOPA 200MG TAB,SA AWARDED FOR A BASE YEAR OF 5/23/2025 TO 5/22/2026 PLUS 4 ON-YEAR OPTION PERIODS. | Department of Veterans Affairs | — | Apr 8, 2025 | — |
| 36E79722D0035 6 LINE ITEMS FOR FLUOXETINE HCL CAPSULES. AWARDED FOR A BASE YEAR OF 12/10/2022 TO 12/09/2023 PLUS FOUR ONE-YEAR OPTION PERIODS. | Department of Veterans Affairs | — | Aug 24, 2022 | — |
| 36E79723D0029 AWARD TO RADHA PHARMACEUTICALS INC FOR GABAPENTIN TABLETS FOR THE BASE YEAR WITH FOUR ONE-YEAR OPTIONS. | Department of Veterans Affairs | — | Sep 29, 2023 | — |
| 36E79726D0012 NEW AWARD FOR BUPROPION HCL 12HR SA TABLETS WITH RADHA PHARMACEUTICALS INC. BASE YEAR ORDERING PERIOD IS MAY 16, 2026 TO MAY 15, 2027 WITH FOUR ONE-YEAR OPTIONS. | Department of Veterans Affairs | — | Dec 10, 2025 | — |
| 36E79723D0004 NEW AWARD FOR CLOPIDOGREL BISULFATE TABLETS WITH RADHA PHARMACEUTICALS INC. ORDERING PERIOD IS APRIL 15, 2023 THROUGH APRIL 14, 204 WITH FOUR ONE-YEAR OPTIONS. | Department of Veterans Affairs | — | Oct 28, 2022 | — |
| SPE2D226D0010 4610133531! | Department of Defense | — | Mar 19, 2026 | — |
Sources and method
Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.
Totals sum obligations across every award attributed to this contractor. Obligations are cumulative funding actions, not the value of work delivered.
- 1Awards are attributed by Unique Entity Identifier C1S5SQ88KY67, the government's own recipient identifier, not by name matching.
- 2Award records from USAspending.gov, last refreshed Oct 21, 2026.